Cargando…

Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis

Multiple sclerosis is a complex autoimmune disease caused by a combination of genetic and environmental factors. Translation of Genome-Wide Association Study findings into therapeutics and effective preventive strategies has been limited to date. We used summary-data-based Mendelian randomization to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobs, Benjamin M, Taylor, Thomas, Awad, Amine, Baker, David, Giovanonni, Gavin, Noyce, Alastair J, Dobson, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519728/ https://www.ncbi.nlm.nih.gov/pubmed/33005893 http://dx.doi.org/10.1093/braincomms/fcaa119

Ejemplares similares

BMI and low vitamin D are causal factors for multiple sclerosis: A Mendelian Randomization study
por: Jacobs, Benjamin M., et al.
Publicado: (2020)

Age-specific effects of childhood body mass index on multiple sclerosis risk
por: Hone, Luke, et al.
Publicado: (2022)

Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study
por: Jacobs, Benjamin Meir, et al.
Publicado: (2021)

No evidence for association between polygenic risk of multiple sclerosis and MRI phenotypes in ~30,000 healthy adult UK Biobank participants
por: Jacobs, Benjamin Meir, et al.
Publicado: (2022)

Vitamin D genetic risk scores in multiple sclerosis
por: Kuri, Ashvin, et al.
Publicado: (2022)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
por: Ferreira-Atuesta, Carolina, et al.
Publicado: (2021)

Predicting Multiple Sclerosis: Challenges and Opportunities
por: Hone, Luke, et al.
Publicado: (2022)

Mendelian Randomization — the Key to Understanding Aspects of Parkinson's Disease Causation?
por: Noyce, Alastair J., et al.
Publicado: (2015)

The BRAIN test: a keyboard-tapping test to assess disability and clinical features of multiple sclerosis
por: Shribman, Samuel, et al.
Publicado: (2017)

Systematic review and meta-analysis of the association between Epstein–Barr virus, multiple sclerosis and other risk factors
por: Jacobs, Benjamin M, et al.
Publicado: (2020)

No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19
por: Gaziano, Liam, et al.
Publicado: (2021)

Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses
por: Zhang, Naiqi, et al.
Publicado: (2023)

Big data, machine learning and artificial intelligence: a neurologist’s guide
por: Auger, Stephen D, et al.
Publicado: (2021)

Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization
por: Williams, Dylan M., et al.
Publicado: (2020)

Obesity and Multiple Sclerosis: A Mendelian Randomization Study
por: Mokry, Lauren E., et al.
Publicado: (2016)

Polygenic risk score prediction of multiple sclerosis in individuals of South Asian ancestry
por: Breedon, Joshua R, et al.
Publicado: (2023)

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
por: Storm, Catherine S., et al.
Publicado: (2021)

In silico Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization
por: Michel, Maurice, et al.
Publicado: (2020)

Social determinants of neurological disease: tackling inequalities
por: Dobson, Ruth, et al.
Publicado: (2022)

Enhancer promoter interactome and Mendelian randomization identify network of druggable vascular genes in coronary artery disease
por: Chignon, Arnaud, et al.
Publicado: (2022)

Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data
por: Kumar, Runjun D., et al.
Publicado: (2013)

Smoking and multiple sclerosis risk: a Mendelian randomization study
por: Vandebergh, Marijne, et al.
Publicado: (2020)

Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease
por: Su, Wei-Ming, et al.
Publicado: (2023)

Little evidence for an effect of smoking on multiple sclerosis risk: A Mendelian Randomization study
por: Mitchell, Ruth E., et al.
Publicado: (2020)

Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study
por: Kang, Xiaoying, et al.
Publicado: (2021)

Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization
por: Taylor, Kurt, et al.
Publicado: (2019)

Deep structured learning for variant prioritization in Mendelian diseases
por: Danzi, Matt C., et al.
Publicado: (2023)

A service development study of the assessment and management of fracture risk in Parkinson’s disease
por: Shribman, Samuel, et al.
Publicado: (2014)

Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study
por: Mokry, Lauren E., et al.
Publicado: (2015)

An atlas on risk factors for multiple sclerosis: a Mendelian randomization study
por: Yuan, Shuai, et al.
Publicado: (2020)

Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study
por: Lu, Hui, et al.
Publicado: (2021)

Multiple Sclerosis and the Risk of Cardiovascular Diseases: A Mendelian Randomization Study
por: Yang, Fangkun, et al.
Publicado: (2022)

Physical activity and risk of multiple sclerosis: A Mendelian randomization study
por: Li, Chunyu, et al.
Publicado: (2022)

Lower Lymphocyte Count is Associated With Increased Risk of Parkinson’s Disease
por: Jensen, Melanie P., et al.
Publicado: (2021)

The Refinement of Genetic Predictors of Multiple Sclerosis
por: Disanto, Giulio, et al.
Publicado: (2014)

KRAS: Druggable at Last
por: Herzberg, Benjamin O, et al.
Publicado: (2023)

Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases
por: Yuan, Xiao, et al.
Publicado: (2022)

Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases
por: Jacobsen, Julius O B, et al.
Publicado: (2022)

Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine
por: Pakpoor, Julia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tjl1lume0jkq1a80m7p4ertq84